Johnson & Johnson (JNJ)

179.52 +2.01 (+1.13%)
Closed USD Disclaimer
179.27 -0.25 (-0.14%)

JNJ Financial Summary

For the three months ended 03 April 2022, Johnson & Johnson revenues increased 5% to $23.43B. Net income decreased 17% to $5.15B. Revenues reflect Pharmaceutical segment increase of 6% to $12.87B, Medical Devices segment increase of 6% to $6.97B, Europe segment increase of 11% to $6.02B, United States segment increase of 3% to $11.41B. Net income was offset by Acquisition and Integration related decrease from $600M (income) to $0K.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
JNJ
Gross margin TTM 67.97%
Operating margin TTM 22.35%
Net Profit margin TTM 20.9%
Return on Investment TTM 14.88%
Total Revenue
Net Income
Title
Apr 03, 2022
Jan 02, 2022
Oct 03, 2021
Jul 04, 2021
Total Revenue 23,426 24,804 23,338 23,312
Gross Profit 15,828 16,849 16,088 15,725
Operating Income 5,862 4,836 3,849 6,662
Net Income 5,149 4,736 3,667 6,278
Clear All
0Selected
Please try another search
JNJ
Quick Ratio MRQ 1.14
Current Ratio MRQ 1.39
LT Debt to Equity MRQ 38.62%
Total Debt to Equity MRQ 44.37%
Total Assets
Total Liabilities
Title
Apr 03, 2022
Jan 02, 2022
Oct 03, 2021
Jul 04, 2021
Total Assets 178,355 182,018 179,228 176,440
Total Liabilities 103,646 107,995 108,956 106,860
Total Equity 74,709 74,023 70,272 69,580
Clear All
0Selected
Please try another search
JNJ
Cash Flow/Share TTM 10.14
Revenue/Share TTM 35.52
Operating Cash Flow 9.17%
Cash
Net Change in Cash
Title
Apr 03, 2022
Jan 02, 2022
Oct 03, 2021
Jul 04, 2021
Cash From Operating Activities 3,979 23,410 17,678 9,388
Cash From Investing Activities -3,634 -8,683 -3,323 -604
Cash From Financing Activities -4,385 -14,047 -10,611 -8,404
Net Change in Cash -4,024 502 3,619 347
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.